EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction

Ming Zhu, Daisuke Douchi iD, Keigo Murakami, Taito Itoh, Shusuke Migita, Naoki Rikiyama, Shuichiro Hayashi, Takashi Kokumai, Hideaki Sato, Shingo Yoshimachi, Akiko Kusaka, Mitsuhiro Shimura und 12 weitere

Journal of Gastroenterology · 2026

DOI: 10.1007/s00535-025-02303-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, 2026. Verfasst von Ming Zhu und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, Japan. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Pancreaticobiliary Maljunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreaticobiliary maljunction (PBM) contributes to epithelial hyperplasia and, ultimately, the development of gallbladder cancer (GBC). Despite its clinical significance, the molecular and cellular mechanisms driving carcinogenesis in GBC with PBM remain poorly elucidated. This study investigated the oncogenic mechanisms, biomarkers, and performance associated with Erb-b2 receptor tyrosine kinase 2 ( ERBB2) -targeted therapies in GBC with PBM.

Methods

Overall, 127 surgically treated patients were stratified as follows: Group A, normal gallbladder; Group B, PBM; Group C, GBC without PBM; and Group D, GBC with PBM. We performed whole-exome sequencing (WES) for Group D and human epidermal growth factor receptor 2 immunohistochemistry (HercepTest) for the entire cohort. Fluorescence in situ hybridization (FISH) was used to clarify human epidermal growth factor receptor 2 (HER2) expression in cases with equivocal HercepTest results.

Results

ERBB2 amplification was detected in 50% of Group D patients. The proportion of HER2 protein expression scores ≥ 2 + was highest in Group D compared with that in the other groups (50.0% vs. 0% in Groups A and B and 15.6% in Group C) ( P = 0.006, chi-squared test). Finally, 37.5% and 13.3% of cases in Groups D and C, respectively, showed HER2 overexpression ( P = 0.037, chi-squared test).

Conclusions

This is the first evaluation of HER2/ ERBB2 expression in GBC with PBM based on WES, HercepTest, and FISH. The significant increase in ERBB2 expression, driven by the synergistic interplay between GBC and PBM, underscores a critical molecular interaction that may inform the development of targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallbladder NeoplasmsErb-b2 Receptor Tyrosine KinasesPancreaticobiliary MaljunctionHumansFemaleMaleMiddle AgedAgedIn Situ Hybridization, FluorescenceGene AmplificationCarcinogenesisBiomarkers, TumorAdultExome SequencingImmunohistochemistryAged, 80 and over

Stichwörter der Autor:innen

ERBB2Gallbladder cancerHER2Pancreaticobiliary maljunction

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, Japan.
  • Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, Japan. daisuke.douchi.e6@tohoku.ac.jp.
  • Department of Investigative Pathology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, Japan.
  • Laboratory of Molecular Diagnostics and Therapeutics, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, 7-6-8 Saito-Asagi, Ibaraki, Osaka, Japan.
  • Division of Gastroenterological and Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Miyagino-Ku, Sendai, Miyagi, Japan.
  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, Japan.

ORCID-Profile: Daisuke Douchi

Zitieren

APA

Zhu, M., Douchi, D., Murakami, K., Itoh, T., Migita, S., Rikiyama, N., Hayashi, S., Kokumai, T., Sato, H., Yoshimachi, S., Kusaka, A., Shimura, M., Nakayama, S., Aoki, S., Iseki, M., Miura, T., Maeda, S., Ishida, M., Ohtsuka, H., …, & Unno, M. (2026). Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction. Journal of Gastroenterology. https://doi.org/10.1007/s00535-025-02303-2

Vancouver

Zhu M, Douchi D, Murakami K, Itoh T, Migita S, Rikiyama N, et al. Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction. Journal of Gastroenterology. 2026. doi:10.1007/s00535-025-02303-2

BibTeX
@article{Zhu2026,
  author = {Zhu, Ming and Douchi, Daisuke and Murakami, Keigo and Itoh, Taito and Migita, Shusuke and Rikiyama, Naoki and Hayashi, Shuichiro and Kokumai, Takashi and Sato, Hideaki and Yoshimachi, Shingo and Kusaka, Akiko and Shimura, Mitsuhiro and Nakayama, Shun and Aoki, Shuichi and Iseki, Masahiro and Miura, Takayuki and Maeda, Shimpei and Ishida, Masaharu and Ohtsuka, Hideo and Mizuma, Masamichi and Nakagawa, Kei and Masamune, Atsushi and Furukawa, Toru and Unno, Michiaki},
  title = {Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction},
  journal = {Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s00535-025-02303-2}
}
Kostenlos starten →